Category: Metabolic and Bariatric Surgery

EndoBarrier Shows Promise for Type 2 Diabetes in Obesity

Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity. At one year, HbA1c levels dropped by 1.10% in the DJBL group, compared to just 0.28% in the sham group (p=0.0004). Patients with HbA1c ≤ 7% more than tripled in the DJBL group […]

Roux-en-Y Gastric Bypass Reversal Insights for Surgeons

Roux-en-Y gastric bypass (RYGB) reversal is rare but offers significant symptom relief for select patients with complications. 199 patients underwent RYGB reversal over 16 years, 0.3% of 63,797 RYGBs. 86% reported symptom relief; highest in those with postbariatric hypoglycemia (94.6%). Complications are common: 24.6% had early severe complications, 21.6% experienced late complications. Careful patient selection […]

Study Reveals Gaps in Innovative Bariatric Surgery Oversight

Surgeons should be alert to significant issues in the implementation of non-standard metabolic bariatric surgeries. 57 studies analyzed involved 10,754 patients; median from first operation to publication was 5 years. Only 11% had prospective trial registration; 26% reported outcomes at 3 years or more. These findings point to systemic failures in monitoring experimental procedures, emphasizing […]

New Magnetic Compression Technique Enhances Sleeve Gastrectomy Revisional Procedures

A novel magnetic compression gastroileostomy bipartition (MagGI) shows promising early outcomes in patients needing revisional surgery after sleeve gastrectomy. 100% feasibility in magnet placement and creation of patent anastomosis across 20 patients. Weight loss at 12 months averaged 23.4% total and 66.0% of excess weight; significant BMI reduction observed. Surgeons can consider MagGI as a […]

Preoperative Low-Energy Diets May Reduce Surgical Risks

Patients with obesity undergoing non-bariatric surgery who follow low-energy diets show promise for better outcomes. In a pilot study, 91 patients were randomized to a low-energy diet or standard care; adherence to the diet was 81.7%. Patients on the diet lost an average of 4.5 kg in three weeks. A meta-analysis indicated an 18% relative […]

Obesity Linked to Higher Cancer Rates: Significant Implications for Surgery

Surgeons should recognize that managing obesity could notably decrease cancer rates among patients. Obesity contributes to about 10% of new cancer diagnoses in the U.S., with specific cancers like endometrial and hepatobiliary seeing rates as high as 50%. Patients losing over 10% of their body weight through bariatric surgery or medication showed modest reductions in […]

Gas Bloat Syndrome Post-Nissen Fundoplication Linked to Failures

Gas bloat syndrome significantly worsens outcomes after Nissen fundoplication, revealing critical insights for surgical practice. 24.7% of patients experienced gas bloat syndrome one year post-surgery. Those with gas bloat reported higher GERD-HRQL scores, lower satisfaction, and increased PPI use (p < 0.01). By year five, 46.7% of gas bloat patients had anatomical failures vs. 15.3% […]

Midterm Insights on Weight Loss in Bariatric Surgery

One-anastomosis gastric bypass leads to greater weight loss but carries higher gastrointestinal complication risks compared to sleeve gastrectomy. Patients had similar preoperative BMI: around 41 kg/m. One-anastomosis gastric bypass resulted in more significant weight loss but saw increased complications. Surgeons should weigh weight loss benefits against potential complications when choosing bariatric procedures. Journal Article by […]

10-Year Outcomes: Distal vs. Standard Roux-en-Y Bypass

Distal Roux-en-Y gastric bypass results in greater long-term weight loss but carries higher risks of nutritional deficiencies. Mean BMI reduction after standard RYGB was 12.0 kg/m2 vs. 14.7 kg/m2 for distal RYGB, a significant difference of 2.7 kg/m2. Total weight loss percentage was 23.0% for standard vs. 28.2% for distal, a difference of 5.3% (p […]

Impact of Preoperative Cannabis Use on Gastroparesis Surgery

Preoperative cannabis use leads to worse outcomes after surgery for gastroparesis, indicating patient selection is crucial. Cannabis users had a higher reintervention rate within 90 days (9.3% vs 1.2%) and more inpatient admissions (32.4% vs 23.7%). Over 5 years, they faced higher hospital admission rates (59.3% vs 41.0%) and showed less outpatient engagement (54.6% attended […]